Survival and Side Effects in Non-Small Cell Lung Cancer Patients Treated With Combination of Chemotherapy and Conformal Radiotherapy
Journal
Open Access Macedonian Journal of Medical Sciences
Date Issued
2018-12-20
Author(s)
DOI
10.3889/oamjms.2018.490
Abstract
Combined modality therapy is standard of care for patients with inoperable locally advanced non-small cell lung cancer (NSCLC), however, insufficient data exist regarding what chemoradiotherapy combination will be the gold standard.
